Amgen stock posts a 27.1 price-to-earnings ratio
Published on 10/16/2026 at 15:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSValuation and market position
- Amgen stock carried a 27.1 price-to-earnings ratio on October 16, 2026.
- Amgen's market capitalization stood at USD 236.0 billion on October 16, 2026.
- Amgen stock costs EUR 389.58 at Lang & Schwarz on October 16, 2026 at 3:38 p.m. CEST, 0.83 percent below the Xetra close of October 15, 2026.
- Amgen's year-to-date performance was minus 40.15 percent as of October 15, 2026.
At 27.1, Amgen stock's price-to-earnings ratio put valuation at the center of the October 16, 2026 market picture. The euro quote stood at EUR 389.58 at Lang & Schwarz at 3:38 p.m. CEST, down 0.83 percent versus the Xetra close of October 15, 2026 at EUR 392.85.
Market value reaches USD 236.0 billion
Amgen's market capitalization was USD 236.0 billion on October 16, 2026. The company also carried a 2.00 percent dividend yield on the same finance snapshot, while its price-to-earnings ratio was 27.12.
That valuation sits above Bristol-Myers Squibb's 13.40 ratio and differs sharply from Gilead Sciences' negative 58.57 ratio. The comparison reflects different earnings bases and is descriptive rather than a valuation judgment.
Stock stays below the yearly high
The Xetra quote page lists a 52-week range of EUR 247.65 to EUR 392.85 as of October 15, 2026. The Lang & Schwarz price was EUR 3.27, or 0.83 percent, below that high and EUR 141.93, or 57.30 percent, above the low.
Amgen's year-to-date performance was minus 40.15 percent as of October 15, 2026, while the five-day performance was minus 9.52 percent and the one-month performance was minus 18.26 percent. These figures place the current quote near the top of the reported annual range despite the negative calendar-year result.
Comparison with peers
Euro quote remains near the high
Amgen stock was trading at EUR 389.58 at Lang & Schwarz on October 16, 2026 at 3:38 p.m. CEST, 0.83 percent below the Xetra close of October 15, 2026 at EUR 392.85. The next market signal will come from the stock's earnings calendar and any new analyst revisions.
The further course of trading is shown by the continuously updated real-time quote of Amgen stock.
Amgen stock market data
- Company: Amgen Inc.
- ISIN: US0311621009
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 16, 2026, 3:38 p.m. CEST): EUR 389.58
- Change versus Xetra close: minus 0.83 percent
- Xetra close (October 15, 2026): EUR 392.85
- Market capitalization: USD 236.0 billion (as of October 16, 2026)
- 52-week range: EUR 247.65-EUR 392.85 (as of October 15, 2026)
- Price-to-earnings ratio: 27.12
- Dividend yield: 2.00 percent
Market context: Market report Nasdaq Composite.
